Key points are not available for this paper at this time.
Pediatric heart transplantation is a curative treatment for DCM and CHD with excellent clinical mid-term results. However, further follow-up is necessary to evaluate long-term side effects of immunosuppressants. Donor shortage remains a problem.
Groetzner et al. (Tue,) studied this question.